Eli Lilly and Company has agreed to acquire Merida Biosciences for up to $2.875 billion in cash, adding a precision ...
Health and Me on MSN
Eli Lilly moves beyond GLP-1 drugs, to spend $2.88 billion on autoimmune drug development
Eli Lilly is set to acquire privately-held biotech company Merida Biosciences for up to $2.875 billion in its big move for a ...
Aging may trigger a previously underrecognized change in the brain’s immune system, with protective cells in the hippocampus ...
When the immune system encounters a virus, it produces antibodies designed to recognize and eliminate the invader. But in ...
Our immune system has a dark side: It's supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. New research is raising the prospect of ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. Researchers have found that patients with amyotrophic lateral sclerosis have ...
Scientists from Belgian biotech company etherna, who are working on inverse RNA vaccines for multiple sclerosis and other autoimmune diseases. For decades, the only option available to patients ...
Chennai, Aug. 28 -- Highlights: ...
More than 50 million Americans live with autoimmune disease conditions in which the immune system mistakenly attacks the body ...
A team involving researchers from Wroclaw Medical University analyzed studies of people with schizophrenia spectrum disorders ...
NEW YORK, June 30 (UPI) --For the millions of Americans battling autoimmune disorders, new hope may be on the horizon in the form of reverse or inverse vaccines -- injections that target a specific ...
Our immune system has a dark side: It’s supposed to fight off invaders to keep us healthy. But sometimes it turns traitor and attacks our own cells and tissues. What are called autoimmune diseases can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results